An Integrated Data Driven Approach to Drug Repositioning Using Gene-Disease Associations.
Drug development is both increasing in cost whilst decreasing in productivity. There is a general acceptance that the current paradigm of R&D needs to change. One alternative approach is drug repositioning. With target-based approaches utilised heavily in the field of drug discovery, it becomes...
Main Authors: | Joseph Mullen, Simon J Cockell, Peter Woollard, Anil Wipat |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0155811&type=printable |
Similar Items
-
Mining integrated semantic networks for drug repositioning opportunities
by: Joseph Mullen, et al.
Published: (2016-01-01) -
Integration of probabilistic functional networks without an external Gold Standard
by: Katherine James, et al.
Published: (2022-07-01) -
Systems pharmacology and drug repositioning- an integrated approach to metabolic diseases
by: Luther Michael A
Published: (2012-10-01) -
Data-driven drug repositioning using olfactory omics profiles: challenges and perspectives in neurodegeneration
by: Paz Cartas-Cejudo, et al.
Published: (2025-07-01) -
Transcriptomics-driven drug repositioning for the treatment of diabetic foot ulcer
by: Wirawan Adikusuma, et al.
Published: (2023)